Modulation of paraoxon toxicity by the cannabinoid receptor agonist WIN 55,212-2

Toxicology

Volumn 227, Issue 1-2, 2006, Pages 173-183

  Nallapaneni, Anuradha ^a   Liu, Jing ^a   Karanth, Subramanya ^a   Pope, Carey ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Acetylcholine; Acetylcholinesterase; Cannabinoids; Interaction; Neurotoxicity; Organophosphorus

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ACETYLCHOLINE; ACYLGLYCEROL LIPASE; CANNABINOID RECEPTOR AGONIST; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; FATTY ACID AMIDASE; PARAOXON; WIN 55 212 2;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BINDING; ENZYME ACTIVITY; HIPPOCAMPUS; IN VITRO STUDY; LIGAND BINDING; LOCOMOTION; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

AMIDOHYDROLASES; ANIMALS; BENZOXAZINES; CANNABINOIDS; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSKINESIAS; HIPPOCAMPUS; LIGANDS; MALE; MORPHOLINES; MOTOR ACTIVITY; NAPHTHALENES; PARAOXON; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; RECEPTORS, CANNABINOID;

MAMMALIA;

EID: 33748754631     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2006.08.002     Document Type: Article

References (56)

1. Alger B.E. Endocannabinoids and their implications for epilepsy. Epilepsy Curr. 4 (2004) 169-173
2. Barak L.S., Wilbanks A.M., and Caron M.G. Constitutive desensitization: a new paradigm for G protein-coupled receptor regulation. Assay Drug Dev. Technol. 1 (2003) 339-346
3. Carta G., Nava F., and Gessa G.L. Inhibition of hippocampal acetylcholine release after acute and repeated Delta9-tetrahydrocannabinol in rats. Brain Res. 809 (1998) 1-4
4. Clement A.B., Hawkins E.G., Lichtman A.H., and Cravatt B.F. Increased seizure susceptibility and proconvulsant activity of anandamide in mice lacking fatty acid amide hydrolase. J. Neurosci. 23 (2003) 3916-3923
5. Colgin L.L., Kramar E.A., Gall C.M., and Lynch G. Septal modulation of excitatory transmission in hippocampus. J. Neurophysiol. 90 (2003) 2358-2366
6. Colosio C., Tiramani M., and Maroni M. Neurobehavioral effects of pesticides: state of the art. Neurotoxicology 24 (2003) 577-591
7. Cosenza M., Gifford A.N., Gatley S.J., Pyatt B., Liu Q., Makriyannis A., and Volkow N.D. Locomotor activity and occupancy of brain cannabinoid CB1 receptors by the antagonist/inverse agonist AM281. Synapse 38 (2000) 477-482
8. Cravatt B.F., and Lichtman A.H. Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system. Curr. Opin. Chem. Biol. 7 (2003) 469-475
9. Darmani N.A. The cannabinoid CB1 receptor antagonist SR 141716A reverses the antiemetic and motor depressant actions of WIN 55,212-2. Eur. J. Pharmacol. 430 (2001) 49-58
10. De Bleecker J.L. Intermediate syndrome in organophosphate poisoning. In: Gupta R.C. (Ed). Toxicology of Organophosphate and Carbamate Compounds (2006), Academic Press, San Diego, CA 371-380
11. Di Marzo V., Melck D., Bisogno T., and De Petrocellis L. Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci. 21 (1998) 521-528
12. Drews E., Schneider M., and Koch M. Effects of the cannabinoid receptor agonist WIN 55,212-2 on operant behavior and locomotor activity in rats. Pharmacol. Biochem. Behav. 80 (2005) 145-150
13. Ecobichon D.J. Toxic effects of pesticides. In: Klassen C.D. (Ed). Casarett and Doull's Toxicology. 5th ed. (1996), McGraw-Hill, New York 643-698
14. Fosbraey P., Wetherell J.R., and French M.C. Neurotransmitter changes in guinea-pig brain regions following soman intoxication. J. Neurochem. 54 (1990) 72-79
15. Frazzetto G. Does marijuana have a future in pharmacopoeia?. EMBO Rep. 4 (2003) 651-653
16. Fride E. Endocannabinoids in the central nervous system: from neuronal networks to behavior. Curr. Drug Targets CNS Neurol. Disord. 4 (2005) 633-642
17. Gessa G.L., Mascia M.S., Casu M.A., and Carta G. Inhibition of hippocampal acetylcholine release by cannabinoids: reversal by SR 141716A. Eur. J. Pharmacol. 327 (1997) R1-R2
18. Gifford A.N., and Ashby Jr. C.R. Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A. J. Pharmacol. Exp. Ther. 277 (1996) 1431-1436
19. Gifford A.N., Tang Y., Gatley S.J., Volkow N.D., Lan R., and Makriyannis A. Effect of the cannabinoid receptor SPECT agent, AM 281, on hippocampal acetylcholine release from rat brain slices. Neurosci. Lett. 238 (1997) 84-86
20. Gifford A.N., Bruneus M., Gatley S.J., and Volkow N.D. Cannabinoid receptor-mediated inhibition of acetylcholine release from hippocampal and cortical synaptosomes. Br. J. Pharmacol. 131 (2000) 645-650
21. Glowinski J., and Iversen L.L. Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J. Neurochem. 13 (1966) 655-669
22. Gunderson C.H., Lehmann C.R., Sidell F.R., and Jabbari B. Nerve agents: a review. Neurology 42 (1992) 946-950
23. Gupta R.C. Classification and uses of organophosphates and carbamates. In: Gupta R.C. (Ed). Toxicology of Organophosphate and Carbamate Compounds (2006), Academic Press, San Diego, CA 5-24
24. Hart C.L. Increasing treatment options for cannabis dependence: a review of potential pharmacotherapies. Drug Alcohol Depend. 80 (2005) 147-159
25. Johnson C.D., and Russell R.L. A rapid, simple radiometric assay for cholinesterase, suitable for multiple determinations. Anal. Biochem. 64 (1975) 229-238
26. Kiely T., Donaldson D., and Grube A. Pesticides Industry Sales and Usage (2004), Office of Prevention, Pesticides and Toxic Substances, United States Environmental Protection Agency, Washington, DC
27. Kim J., Isokawa M., Ledent C., and Alger B.E. Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus. J. Neurosci. 22 (2002) 10182-10191
28. Layish I., Krivoy A., Rotman E., Finkelstein A., Tashma Z., and Yehezkelli Y. Pharmacologic prophylaxis against nerve agent poisoning. Isr. Med. Assoc. J. 7 (2005) 182-187
29. Liu J., and Pope C.N. Effects of chlorpyrifos on high-affinity choline uptake and [3H]hemicholinium-3 binding in rat brain. Fundam. Appl. Toxicol. 34 (1996) 84-90
30. Lotti M. Organophosphorus compounds. In: Spencer P.S., and Schaumburg H.H. (Eds). Experimental and Clinical Neurotoxicology. second ed. (2000), Oxford University Press, NY 897-925
31. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
32. Lutz B. On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures. Biochem. Pharmacol. 68 (2004) 1691-1698
33. Marsicano G., Goodenough S., Monory K., Hermann H., Eder M., Cannich A., Azad S.C., Cascio M.G., Gutierrez S.O., van der Stelt M., Lopez-Rodriguez M.L., Casanova E., Schutz G., Zieglgansberger W., Di Marzo V., Behl C., and Lutz B. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302 (2003) 84-88
34. Martin B.R., Sim-Selley L.J., and Selley D.E. Signaling pathways involved in the development of cannabinoid tolerance. Trends Pharmacol. Sci. 25 (2004) 325-330
35. Mechoulam R., Ben Shabat S., Hanus L., Fride E., Vogel Z., Bayewitch M., and Sulcova A.E. Endogenous cannabinoid ligands-chemical and biological studies. J. Lipid Mediat. Cell Signal. 14 (1996) 45-49
36. Mechoulam R., Fride E., and Di Marzo V. Endocannabinoids. Eur. J. Pharmacol. 359 (1998) 1-18
37. Mishima K., Egashira N., Matsumoto Y., Iwasaki K., and Fujiwara M. Involvement of reduced acetylcholine release in Delta9-tetrahydrocannabinol-induced impairment of spatial memory in the 8-arm radial maze. Life Sci. 72 (2002) 397-407
38. Motulsky H.J. Analyzing Data with GraphPad Prism (1999), GraphPad Software, Inc., San Diego, CA
39. Ohno-Shosaku T., Maejima T., and Kano M. Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 29 (2001) 729-738
40. Pope C.N., Chakraborti T.K., Chapman M.L., Farrar J.D., and Arthun D. Comparison of in vivo cholinesterase inhibition in neonatal and adult rats by three organophosphorothioate insecticides. Toxicology 68 (1991) 51-61
41. Pope C., Karanth J., and Liu J. Pharmacology and toxicology of cholinesterase inhibitors: uses and misuses of a common mechanism of action. Environ. Toxicol. Pharmacol. 19 (2005) 433-446
42. Quistad G.B., Sparks S.E., and Casida J.E. Fatty acid amide hydrolase inhibition by neurotoxic organophosphorus pesticides. Toxicol. Appl. Pharmacol. 173 (2001) 48-55
43. Quistad G.B., Nomura D.K., Sparks S.E., Segall Y., and Casida J.E. Cannabinoid CB1 receptor as a target for chlorpyrifos oxon and other organophosphorus pesticides. Toxicol. Lett. 135 (2002) 89-93
44. Quistad G.B., Klintenberg R., Caboni P., Liang S.N., and Casida J.E. Monoacylglycerol lipase inhibition by organophosphorus compounds leads to elevation of brain 2-arachidonoylglycerol and the associated hypomotility in mice. Toxicol. Appl. Pharmacol. 211 (2006) 78-83
45. Ray D.E., and Richards P.G. The potential for toxic effects of chronic, low-dose exposure to organophosphates. Toxicol. Lett. 120 (2001) 343-351
46. SAS. Statistics and Graphics Guide, Version 3 (1995), SAS Institute, Cary, NC
47. Savage E.P., Keefe T.J., Mounce L.M., Heaton R.K., Lewis J.A., and Burcar P.J. Chronic neurological sequelae of acute organophosphate pesticide poisoning. Arch. Environ. Health 43 (1988) 38-45
48. Shafaroodi H., Samini M., Moezi L., Homayoun H., Sadeghipour H., Tavakoli S., Hajrasouliha A.R., and Dehpour A.R. The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice. Neuropharmacology 47 (2004) 390-400
49. Shaikh J., Karanth S., Chakraborty D., Pruett S., and Pope C.N. Effects of daily stress or repeated paraoxon exposures on subacute pyridostigmine toxicity in rats. Arch. Toxicol. 77 (2003) 576-583
50. Sim-Selley L.J. Regulation of cannabinoid receptors in the central nervous system by chronic cannabinoids. Crit. Rev. Neurobiol. 15 (2003) 91-119
51. Steenland K., Jenkins B., Ames R.G., O'Malley M., Chrislip D., and Russo J. Chronic neurological sequelae to organophosphate pesticide poisoning. Am. J. Public Health 84 (1994) 731-736
52. Steffens M., Szabo B., Klar M., Rominger A., Zentner J., and Feuerstein T.J. Modulation of electrically evoked acetylcholine release through cannabinoid CB1 receptors: evidence for an endocannabinoid tone in the human neocortex. Neuroscience 120 (2003) 455-465
53. Tzavara E.T., Wade M., and Nomikos G.G. Biphasic effects of cannabinoids on acetylcholine release in the hippocampus: site and mechanism of action. J. Neurosci. 23 (2003) 9374-9384
54. von Zastrow M. Opioid receptor regulation. Neuromol. Med. 5 (2004) 51-58
55. Wesseling C., Keifer M., Ahlbom A., McConnell R., Moon J.D., Rosenstock L., and Hogstedt C. Long-term neurobehavioral effects of mild poisonings with organophosphate and N-methyl carbamate pesticides among banana workers. Int. J. Occup. Environ. Health 8 (2002) 27-34
56. Wilson R.I., and Nicoll R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410 (2001) 588-592